Seven late relapses of acute lymphoblastic leukemia occurring 5.5 t o 12.3 years after cessation of therapy are reported in 986 patients who had discontinued treatment for leukemia acquired before the age of 15. The study covers patients from the five Nordic countries. Of the 434 patients with ALL w
Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries
✍ Scribed by Erik Forestier; Bertil Johansson; Georg Borgström; Gitte Kerndrup; Johann Johannsson; Sverre Heim; The NOPHO Leukemia Cytogenetic Study Group
- Book ID
- 114422890
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 109 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0902-4441
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Between 1992 and 2004, 1,140 children (1 to <15 years) were diagnosed with B‐cell precursor acute lymphoblastic leukemia (ALL) in the Nordic countries. Of these, 288 (25%) were positive for t(12;21)(p13;q22) [__ETV6/RUNX1__]. G‐banding analyses were successful in 245 (85%); 43 (15%) wer
## Background: The authors have determined the prognostic significance of cytogenetically detectable 12p abnormalities, which are frequent in children with acute lymphoblastic leukemia (all), in a large cohort of patients treated on risk-adjusted protocols of the children's cancer group (ccg). ##
## Abstract This study reports the outcome after relapse of acute lymphoblastic leukemia (ALL) in a population‐based study of 809 children over 1 year of age diagnosed July 1981 through June 1986 and with non‐B acute lymphoblastic leukemia in the five Nordic countries. By January 1994, 315 children